ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

4.96
0.14
(2.90%)
Closed November 21 3:00PM
4.96
-0.015
(-0.30%)
After Hours: 5:55PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.96
Bid
4.62
Ask
5.10
Volume
1,244,848
4.745 Day's Range 5.039
4.275 52 Week Range 11.555
Market Cap
Previous Close
4.82
Open
4.85
Last Trade
7
@
5.06
Last Trade Time
Financial Volume
US$ 6,080,616
VWAP
4.8846
Average Volume (3m)
1,814,133
Shares Outstanding
252,527,585
Dividend Yield
-
PE Ratio
-10.54
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$4.82. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.275 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares outstanding. The market capitalization of Maravai LifeSciences is US$1.22 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -10.54.

MRVI Latest News

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is...

Maravai LifeSciences plant die Übernahme des DNA- und RNA-Geschäfts von Officinae Bio und fördert damit die Unterstützung innovativer Nukleinsäureforschung

Durchbrüche von Officinae Bio bei KI-gestützten Methoden zur Nukleinsäureherstellung zur Verbesserung der mRNA-Herstellungskapazitäten von Maravai innerhalb des TriLink...

Maravai LifeSciences prévoit d’acquérir les activités ADN et ARN d’Officinae Bio afin de renforcer son soutien à la recherche innovante sur les acides nucléiques

Les percées d’Officinae Bio dans les méthodologies de fabrication d’acides nucléiques basées sur l’IA vont renforcer les capacités de fabrication d’ARNm de Maravai au sein de l’entreprise TriLink...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.569-10.29119189735.5295.544.27525964444.66631312CS
4-2.43-32.88227334247.398.19274.27525360905.89909708CS
12-4.23-46.02829162139.199.64.27518141337.23007163CS
26-6.25-55.753791257811.2111.49994.27520965377.97863508CS
520.010.202020202024.9511.5554.27522539937.60127705CS
156-32.49-86.755674232337.4546.294.275208221115.09366487CS
260-26.15-84.056573449131.1163.554.275192827019.67685551CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
US$ 2.12
(116.33%)
144.38M
CRNCCerence Inc
US$ 5.83
(106.74%)
77.55M
PROCProcaps Group SA
US$ 1.10
(92.48%)
2.58M
IBGInnovation Beverage Group Limited
US$ 1.19
(50.40%)
12.97M
ARQQArqit Quantum Inc
US$ 10.7599
(46.59%)
900.38k
SKKSKK Holdings Limited
US$ 1.01
(-77.85%)
40.45M
TMTCTMT Acquisition Corporation
US$ 2.20
(-65.84%)
530.14k
WCTWellchange Holdings Company Limited
US$ 1.2596
(-62.06%)
2.34M
TMTCUTMT Acquisition Corporation
US$ 2.89
(-56.74%)
14.07k
GLXGGalaxy Payroll Group Ltd
US$ 1.77
(-54.73%)
2.45M
CDTConduit Pharmaceuticals Inc
US$ 0.1048
(13.54%)
579M
NVDANVIDIA Corporation
US$ 146.67
(0.53%)
401.66M
ELABElevai Labs Inc
US$ 0.020072
(-6.21%)
256.24M
AKTSAkoustis Technologies Inc
US$ 0.1022
(17.34%)
211.19M
MARAMARA Holdings Inc
US$ 24.19
(6.89%)
166.43M

MRVI Discussion

View Posts
Monksdream Monksdream 9 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 9 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock